Dual antiplatelet therapy in recurrent stroke prevention: do the benefits outweigh the risks?

Evid Based Med. 2014 Aug;19(4):137. doi: 10.1136/eb-2013-101642. Epub 2014 Feb 11.

Authors

Muhammad U Farooq¹, Philip B Gorelick²

Affiliations

¹ Section of Vascular Neurology and Stroke, Hauenstein Neuroscience Center, Grand Rapids, Michigan, USA;
² Michigan State University, Grand Rapids, Michigan, USA.

PMID: 24520127
DOI: 10.1136/eb-2013-101642

No abstract available

Keywords: Stroke Medicine.

Publication types

Comment

MeSH terms

Anticoagulants / adverse effects*
Anticoagulants / therapeutic use*
Brain Ischemia / prevention & control*
Humans
Platelet Aggregation Inhibitors / adverse effects*
Platelet Aggregation Inhibitors / therapeutic use*
Stroke / prevention & control*

Substances

Anticoagulants
Platelet Aggregation Inhibitors